Fat metabolism research fragment
AOD-9604.
3 vendors · A$56
Modified C-terminal fragment of human growth hormone (hGH 177–191). Researched for adipose-tissue mechanisms; not approved for human therapeutic use.
Live vendor register · grouped by strength
Every vendor. Cheapest per mg first, kits listed separately.
AOD-9604 · price per mg
3 listings · unflagged vendors first · Listings data last updated October 2026
Best price per mg: Pepsup 5 mg at A$11.20/mg.
5 mg
1 listing01
PepsupVID-PEPSUP · €34.99 · duties on delivery
5 mg
99%
No COA published (mfr claim 99%+)
In stock
NL dispatch · PostNL Tracked 2–5 business days
A$11.20/mg
A$56
Kits · multi-vial packs, price per vial
01
2 mgkit of 10
99%
HPLC · MS · Janoshik
In stock
3–7 days (AU warehouse)
A$14.00/mg
A$28≈ A$280 per kit
Flagged vendors · documented, never recommended
01
Pharma Lab GlobalVID-PHARMA-L · UK dispatch · from £18.86
2 mg
99%
HPLC certificates
In stock
10–14 days
A$17.50/mg
A$35
Same research area
Similar compounds.
GH secretagogue research
Ipamorelin
Synthetic pentapeptide described in 1998 by Novo Nordisk researchers as a selective ghrelin/GH-secretagogue receptor agonist; researched for growth-hormone release. Not approved for human therapeutic use.
4 vendorsA$25–40
GHRH analogue research
CJC-1295
GHRH(1-29) analogue developed by ConjuChem; the DAC form binds albumin and persists for days, the no-DAC form (Mod GRF 1-29) is short-acting. Researched for GH/IGF-1 stimulation; not approved for human therapeutic use.
4 vendorsA$48–60
GIP/GLP-1 dual agonist research
Tirzepatide
Dual GIP/GLP-1 receptor agonist, FDA- and EMA-approved as Mounjaro and Zepbound. Research-vial tirzepatide is a different, unapproved product, not made or reviewed as those medicines, and not for human use.
2 vendorsA$145
Triple hormone agonist research
Retatrutide
Investigational triple GIP/GLP-1/glucagon receptor agonist (LY3437943) developed by Eli Lilly and studied in Phase 3 trials; not approved as a medicine anywhere and not for human therapeutic use.
2 vendorsA$113
GLP-1 receptor agonist research
Semaglutide
GLP-1 receptor agonist, FDA- and EMA-approved as Ozempic, Wegovy and Rybelsus. Research-vial semaglutide is a different, unapproved product, not made or reviewed as those medicines, and not for human use.
1 vendorA$21per vial · kits only
Amylin analogue research
Cagrilintide
Long-acting amylin-receptor agonist (AM833 / NNC0174-0833) developed by Novo Nordisk, studied alone and in the CagriSema combination; not approved as a medicine anywhere and not for human therapeutic use.
1 vendorA$56per vial · kits only
Long-form research guide
Weight Loss Research. Mechanism + protocols + safety.
Lipolysis, GH secretagogues, and adipose tissue modulation in obesity models
Open the long-form guide for AOD-9604 →